Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

NCT05063877 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Equilibre Biopharmaceuticals B.V.